Camargo Pharmaceutical Services Expands Biologics Service Offering and Appoints Chief Medical Officer

(BUSINESS WIRE)--Camargo Pharmaceutical Services, a full-service clinical research organization (CRO) specializing in end-to-end drug development through the 505(b)(2) process, is pleased to announce the Company’s appointment of Ray Dawkins, M.D., as chief medical officer.

Back to news